Encompass Health (NYSE:EHC) Shares Down 6.2% - What's Next?

Encompass Health Corporation (NYSE:EHC - Get Free Report)'s share price fell 6.2% during mid-day trading on Tuesday . The stock traded as low as $113.75 and last traded at $112.29. 437,545 shares traded hands during mid-day trading, a decline of 38% from the average session volume of 708,643 shares. The stock had previously closed at $119.67.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on EHC. KeyCorp raised their target price on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday, May 27th. Barclays raised their price target on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. Truist Financial reaffirmed a "buy" rating and issued a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Stephens raised shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. Finally, UBS Group raised their price target on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Seven equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $131.50.

Encompass Health Stock Up 2.5%

The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81. The firm has a market cap of $11.08 billion, a PE ratio of 22.72, a P/E/G ratio of 2.18 and a beta of 0.88. The business's 50-day simple moving average is $119.30 and its 200 day simple moving average is $106.57.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The company's revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.12 EPS. As a group, equities research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st were given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date of this dividend was Tuesday, July 1st. Encompass Health's payout ratio is currently 14.05%.

Insider Transactions at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider owned 11,958 shares of the company's stock, valued at $1,394,422.38. The trade was a 26.35% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the transaction, the executive vice president directly owned 79,710 shares in the company, valued at approximately $9,149,910.90. The trade was a 11.15% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 132,663 shares of company stock valued at $16,034,082 in the last 90 days. Insiders own 2.00% of the company's stock.

Institutional Trading of Encompass Health

Large investors have recently bought and sold shares of the stock. WPG Advisers LLC purchased a new stake in Encompass Health during the 1st quarter worth approximately $27,000. Colonial Trust Co SC purchased a new stake in shares of Encompass Health in the 4th quarter valued at $29,000. Transce3nd LLC purchased a new stake in shares of Encompass Health in the 4th quarter valued at $40,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of Encompass Health by 749.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company's stock valued at $42,000 after acquiring an additional 367 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after acquiring an additional 125 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.